(Q62110007)

English

TNX-355 With Optimized Background Therapy (OBT) in Treatment-Experienced Subjects With HIV-1

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Three-Arm Study of the Anti-CD4 Monoclonal Antibody TNX-355 With Optimized Background Therapy in Treatment-Experienced Subjects Infected With HIV-1 (English)

0 references

country

Canada

0 references

United States of America

0 references

located in the administrative territorial entity

0 references

0 references

March 2004

0 references

number of participants

80

0 references

clinical trial phase

phase II clinical trial

0 references

research site

University of Miami

0 references

research subject recruitment status

unknown

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT00089700

0 references

(Q62110007)

TNX-355 With Optimized Background Therapy (OBT) in Treatment-Experienced Subjects With HIV-1

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)